Showing results (41-50 of 78) with videos related to
Sort By:
Pageof 8
American Journal of Clinical Oncology|June 14, 2022
A Phase I Study of Apolizumab, an Anti-HLA-DR ß-chain Monoclonal Antibody, in Patients With Solid Tumor MalignanciesPaula M Fracasso, Sherry A Goodner, Jonathan D Wildi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2011
BEAM: a randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced melanomaKevin B Kim, Jeffrey A Sosman, John P Fruehauf, et al.Cancer Immunology, Immunotherapy : CII|February 6, 2019
Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinomaSandra P D'Angelo, Matthias Hunger, Andrew S Brohl, et al.Cancer Immunology Research|June 13, 2024
Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen ReceptorsJu-Fang Chang, Nils Wellhausen, Nils W Engel, et al.Cancer Chemotherapy and Pharmacology|April 17, 2008
Phase 1 and pharmacokinetic study of weekly docosahexaenoic acid-paclitaxel, Taxoprexin, in resistant solid tumor malignanciesPaula M Fracasso, Joel Picus, Jonathan D Wildi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Immunization using autologous dendritic cells pulsed with the melanoma-associated antigen gp100-derived G280-9V peptide elicits CD8+ immunityGerald P Linette, Dongsheng Zhang, F Stephen Hodi, et al.Melanoma Research|October 28, 2017
Vemurafenib treatment for patients with locally advanced, unresectable stage IIIC or metastatic melanoma and activating exon 15 BRAF mutations other than V600ESigrun Hallmeyer, Rene Gonzalez, David H Lawson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2005
Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapyLynn C Hartmann, Karen H Lu, Gerald P Linette, et al.The Lancet. Oncology|September 6, 2016
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trialHoward L Kaufman, Jeffery Russell, Omid Hamid, et al.Neuro-Oncology|November 29, 2013
Codeletions at 1p and 19q predict a lower risk of pseudoprogression in oligodendrogliomas and mixed oligoastrocytomasAndrew L Lin, Jingxia Liu, John Evans, et al.Pageof 8